Cardiac arrhythmias during pregnancy

C. E L Brown, G. D. Wendel

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations


Arrhythmias of the pregnant patient are rare. In most cases, the therapeutic agent chosen should be much the same as that in the nonpregnant patient, and an understanding of the pharmacology of the antiarrhythmic agents is necessary for rational use in the pregnant patient with an arrhythmia. Substantial experience has been accumulated using some of the older agents for treatment of arrhythmias in pregnancy. As newer agents become available, there may be indications for their use in pregnancy; however, we recommend initially using well-known drugs until more experience is gained with the newer ones. The choice of an agent should be made only after thorough evaluation of the patient's symptoms, accurate diagnosis and an analysis of potential benefit versus potential risk to the mother or fetus.

Original languageEnglish (US)
Pages (from-to)89-102
Number of pages14
JournalClinical Obstetrics and Gynecology
Issue number1
StatePublished - Jan 1 1989

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Cardiac arrhythmias during pregnancy'. Together they form a unique fingerprint.

Cite this